• Skip to main content
  • Skip to footer

GBT Pharma

Experts in OTC market access

  • Our Services
    • International Business Development
    • International Product Development
  • Our Products
    • cannaQIX
    • Klear-vol
    • Estroplus Meno Manage
    • Pediatra Suizo
    • Estroplus™
    • Phytovir®
    • Similasan®
    • Kwai
    • Kira
  • About GBT Pharma
    • Company History
  • GBT Pharma Clients
  • The GBT Pharma Team
    • Our Team in Switzerland
    • Our Team in Latin America
    • Our Team in the UK
  • News
  • Contact Us

May 16, 2014 By Heather Scott

GBT Pharma supports Netherland’s re-launch for Similasan

One of GBT Pharma’s latest projects has seen the team busy re-establishing a presence for Similasan’s eye care range in the Netherlands.

Partnering with the newly founded Dutch subsidiary – Similasan Nederland BV – GBT Pharma has been intensively devising a re-launch programme for this leading brand of allergy eye care products.

Up until 2012, Similasan was the market leading homeopathic eye care brand in the Netherlands. The forthcoming re-launch follows a year long voluntary absence from the Dutch market for the brand.

During this time, GBT Pharma worked closely with Similasan advising on a revised regulatory and customer-facing strategy to support the brand following regulatory changes implemented by the Dutch Ministry of Health in September 2012.

“This is an exciting time to be re-launching Similasan,” comments Gian Trepp, GBT Pharma founder. “Not only is the Dutch market buoyant, after adapting our strategy we will be re-launching four Similasan products as medical devices from June 2014.

“The launch of Similasan’s Dutch branch will support a specific focus on re-establishing this popular brand within key retailers, the independents, drugstores and pharmacies ultimately increasing Similasan’s future role and participation in the Dutch self-care market.

“As well as re-building the Similasan brand in the Netherlands we will be offering in-licensing and product development opportunities to fulfill emerging customer needs in the market,” adds Gian.

Parties interested in listing the Similasan eye care range, or to discuss in-licensing opportunities are invited to contact us: http://www.gbtpharma.com/contact-us

Filed Under: News

Footer

Contact Us

Rte de la Vignettaz 25 |

1700 Fribourg |

Switzerland |

Tel: + 41 79 262 60 43

gian.trepp@gbtpharma.com

About Us

We specialize in developing international markets for our clients. As your partner in driving international growth, GBT Pharma works to quickly understand your business and its objectives.

Follow Us

  • LinkedIn

Copyright © 2025 · GBT Pharma